2024 annual financial data
Lexaria Bioscience 2024 Net margin
Direct answer
Net margin was -1,248.25%.
Operating income was -5,753,130 USD and net income was -5,795,345 USD.
Operating cash flow was -4,959,003 USD.
Get free Lexaria Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 464,278 USD
- Operating income
- -5,753,130 USD
- Net income
- -5,795,345 USD
- Operating cash flow
- -4,959,003 USD